ATNT-21 PRECLINICAL AND INITIAL PHASE 1 EXPERIENCE FOR USE OF MEBENDAZOLE AS UP FRONT THERAPY FOR HIGH GRADE GLIOMA

類似資料

• ATNT-27 ASSESSING THE SAFETY OF COMBINATION THERAPY WITH BEVACIZUMAB AND OPTUNETM FOR HIGH GRADE GLIOMAS
  著者:: Sumrall, Ashley, 等
  出版事項: (2015)
• ATNT-28 MANAGING RECURRENT GRADE III GLIOMAS WITH COMBINATION THERAPY OF BEVACIZUMAB AND OPTUNETM
  著者:: Sumrall, Ashley, 等
  出版事項: (2015)
• ATNT-14 PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA
  著者:: Lee, Eudocia, 等
  出版事項: (2015)
• ATNT-23 TEMOZOLOMIDE FOR "HIGH RISK" LOW-GRADE GLIOMA: THE CLEVELAND CLINIC EXPERIENCE
  著者:: Sarmey, Nehaw, 等
  出版事項: (2015)
• ATNT-03 FIRST IN HUMAN STUDY OF RHENIUM NANOLIPOSOMES FOR INTRATUMORAL THERAPY OF GLIOMA
  著者:: Floyd, John, 等
  出版事項: (2015)